Nextleaf Solutions vision is to hold the largest globally protected patent portfolio within cannabis processing technology. The company manufactures and distributes cannabis vapes and oils from low value, oil grade flower and biomass into high value distillate and cannabinoid ingredients at an industrial scale.,
CLINICAL TRIALS: Yes.
The company has received over 100 patents and 50+ are pending. The company owns 19 US patents and has been issued over 75 patents globally. Patents are for the geographical areas of Europe, parts of South America, Mexico, USA, Canada, South Africa, Cambodia, Australia and New Zealand.
The services offered by the company are toll processing, bulk sales & purchasing and research & product development. Rapid emulsion technology by OILS is a versatile and cost-effective ingredient offering a rapid onset effect and a speed-to-market advantage available as an additional service for commercial partners.
The company’s extraction plant can process 10 times as much biomass as CO2 machines operated by peers.
NEWS & PARTNERSHIPS:
2019
The company acquired IP pertaining to water-soluble cannabinoid formulations based around a nano and micro emulsification process which utilizes food grade emulsifiers approved by Health Canada offering shelf-stability with no constituent separation and a rapid onset time.
The company announced a supply agreement with BevCanna Enterprises which received an exclusive license to use the company’s IP related to water-soluble cannabinoids for the development, manufacturing and sale of BevCanna’s products through its own brands and white label opportunities developed by BevCanna for third parties. A performance milestone of the agreement is the commercialization within 12 months of the legalization of infused products and edibles in Canada. The agreement will extend for 3 years after the legalization of infused products with a subsequent 5-year renewal period.
The company entered into a strategic licensing agreement with a British Columbia-based cannabis processing equipment distribution company which will commercialize and distribute certain IP, three issued and pending patents related to post-extraction processing equipment developed by the company. The company will provide the licensee with initial working capital and strategic support during the indefinite term of the agreement with the option of terminating the agreement should the licensee not meet certain minimum annual sales targets. In turn, the company will receive a 20% royalty of the licensee’s gross revenue from all sources.
The company received a Research Licence under the Cannabis Act.
2020
The company acquired Nextleaf Labs which holds a its standard processor license.
The company signed a 1-year extraction agreement with Eve & Co that will provide cannabis biomass which is to be processed into distilled THC and CBD oils by NextLeaf who will in turn sell it through its commercial partners program and in the wholesale market with the net proceeds to be shared. Once 5,000 KG of cannabis biomass has been processed, the agreement renews for another year.
The company signed a cannabis extraction agreement with a 10-acre greenhouse cannabis cultivator which will provide the company with cannabis biomass until the company has processed 15 metric tons or 12 months has passed and will automatically be renewed for another 12 month-term.
The company entered into a cannabis extraction services agreement with an early Atlantic Canadian pioneer producer that will provide the company with enough product to reach 10 metric tons of biomass or until 12 months has passed.
The company entered into a cannabis extraction services agreement with a Canadian licensed producer operating cannabis production and distribution facilities across Canada. The client will provide 1,000 KG of cannabis biomass which the company will process into THC distillate.
The company acquired IP pertaining to the nano delivery of cannabinoids, including the foundational processing methodology and two water soluble formulations.
The company entered into a cannabis extraction agreement with a premium white label flower producer in Ontario where the client will provide cannabis biomass which the company will process into THC distillate where the extraction services may be paid in-kind, with Nextleaf Labs retaining a portion of the resulting bulk THC distillate. lasting for 12 months or until the company has processed 1,000 KG of marijuana.
The company signed a cannabis extraction agreement with a premium white label flower produce in Ontario and wil last for whichever is first achieved out of 1,000 KG of marijuana having been processed by he company or when a year has passed.
2021
The company received an amendment to its cannabis research licence from Health Canada which allows it to now conduct controlled human administration trials for sensory evaluation of cannabis at its processing facility in Metro Vancouver.
The company acquired Glacial Gold, a brand focused on speciality concentrates and extracts.
The company entered Saskatchewan with its Glacial Gold products.
Langara College was awarded grants worth $3.3 million for its research program which will investigate applications to plant genomics, plant metabolomics, cellular response to cannabinoids, optimization of processing and the use of nanoparticles for delivery of bio-active compounds. The company as well as Pure Sunfarms and Ascension Sciences will in total contribute $400,000 to the project.
The company launched the highest potency CBD oils in Canada (Distilled CBD 100 Oil & Distilled CBD 200 Oil) under its Glacial gold brand.
The USPTO granted the company a patent pertaining to the extraction and purification of THC and CBD.
The company launched a specialty molecules division which is focused on the development and commercialization of novel psychoactive compounds with the inital focus on commercializing more complex cannabinoid-based treatments that may provide a therapeutic alternative to opioid-based medications. Nextleaf intends to develop therapeutic products from its intellectual property pertaining to the acetylation of cannabinoids with the expectation to release adult-use products with THC-O-acetate.
The company engaged CannDelta with respect to its application for a Health Canada controlled drugs and substances dealer’s license which upon approval would allow the company to conduct a variety of activities relating to psilocybin and psilocin including R&D, IP development, production of base substance materials, laboratory analysis, as well as sales and distribution to authorized individuals such as researchers and for its use in clinical trials.
The company announced a hemp processing agreement with Green Light Solutions that will provide NextLeaf with hemp biomass which will be processed into CBD refined oil or distillate.
Launched State B beverages in Canada. The beverages were developed with Nextleaf’s proprietary Rapid Emulsion Technology by OILS. The brand was featured on Dragon’s Den.
2022
The company entered Nova Scotia with its Glacial Gold products.
The company started supplying Hybrid Pharm with its whole suite of cannabinoid-based products from Glacial Gold. Hybrid Pharm is Canada’s first brick and mortal pharmacy which distributes medical cannabis products.whole
The company produced custom manufactured vape cartridges for the partnership with NOYA Cannabis for the launch of Cookies C-branded vapes in the Canadian market.
The company entered into a strategic agreement with Hempcrete Natural, an international construction company creating carbon neutral communities through sustainable, renewable and stronger buildings. The agreement allows Hempcrete Natural to commercialize the company’s US patent related to hemp biomass processing.
The company launched its High Plains brand.
The company launched its first broad spectrum CBD distillate without THC, Rise & Shine CBD Drops.
The company made its first bulk-sale of THC-Free CBD ingredients to a multinational partner.
The company entered the a strategic partnership with Atlantic Cultivation for semi-finished goods which will power several unique products under Atlantic’s Crooked Dory brand.
The company completed its first internatinal shipment of cannabis vape products.
2024
The company launched a VR-tour of its processing facility in Coquitlam BC which features the company’s multi-patented extraction technology. The tour consists of 4 parts: Primary Extraction, Distillation, Manufacturing and The Vault. This was made possible through a grant given by the Canadian Digital Adoption Program.
Miracle Valley became a flagship client of the company’s commercial partnership program and the company launched Miracle Valley’s Crafty Cuts Pre-roll Sampler and Premium Craft Flower in Ontario.
2025
The company launched Yard Cannabis, a brand which offers high-potency extracts, premium hardware and flavor-forward formulations.
BRANDS:
Glacial Gold is prohibition-era brand focused on speciality concentrates and extracts delivered at an accesible price formulated focusing on quality. The brand pioneered processing techniques such as triple-distilled and cold extraction and offers Glacial Gold softgels and infused prerolls.
High Plains is a vape brand offering vape cartridges produced with premium ingredients and hardware components that target consumers looking for products with a high flavor profile.